Page last updated: 2024-09-05

cilengitide and 2019 Novel Coronavirus Disease

cilengitide has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Curley, GF; Fletcher, N; Kerrigan, SW; Nader, D	1

Other Studies

1 other study(ies) available for cilengitide and 2019 Novel Coronavirus Disease

Article	Year
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19. PloS one, 2021, Volume: 16, Issue:6 Topics: Antigens, CD; Binding Sites; Caco-2 Cells; Cadherins; Computer Simulation; COVID-19; Endothelium, Vascular; Host-Pathogen Interactions; Humans; Integrin alphaVbeta3; Models, Molecular; Mutation; Permeability; SARS-CoV-2; Snake Venoms; Spike Glycoprotein, Coronavirus; Virus Internalization	2021

Article

Year

SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19.

PloS one, 2021, Volume: 16, Issue:6

Topics: Antigens, CD; Binding Sites; Caco-2 Cells; Cadherins; Computer Simulation; COVID-19; Endothelium, Vascular; Host-Pathogen Interactions; Humans; Integrin alphaVbeta3; Models, Molecular; Mutation; Permeability; SARS-CoV-2; Snake Venoms; Spike Glycoprotein, Coronavirus; Virus Internalization

2021